Free Trial

ANI Pharmaceuticals (ANIP) Insider Trading & Ownership

ANI Pharmaceuticals logo
$57.55 -0.31 (-0.54%)
(As of 10:10 AM ET)

ANI Pharmaceuticals (NASDAQ:ANIP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$23.60 M
Get ANIP Insider Trade Alerts

Want to know when executives and insiders are buying or selling ANI Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ANIP Insider Buying and Selling by Quarter

ANI Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/14/2024Meredith CookVPSell250$57.19$14,297.50  
9/13/2024Meredith CookVPSell250$56.82$14,205.00  
8/13/2024Meredith CookVPSell250$59.62$14,905.00  
7/17/2024Muthusamy ShanmugamCOOSell14,257$63.16$900,472.12  
7/15/2024Muthusamy ShanmugamCOOSell11,000$63.38$697,180.00  
7/12/2024Meredith CookVPSell250$64.91$16,227.50  
7/1/2024Chad GassertSVPSell20,000$63.44$1,268,800.00  
6/21/2024Muthusamy ShanmugamCOOSell20,000$58.90$1,178,000.00  
6/13/2024Meredith CookVPSell250$63.80$15,950.00  
6/5/2024Ori GutwergSVPSell2,985$67.00$199,995.00  
6/4/2024Stephen P CareyCFOSell5,000$63.58$317,900.00  
6/3/2024Chad GassertSVPSell20,000$64.41$1,288,200.00  
5/21/2024Christopher MutzInsiderSell2,000$61.61$123,220.00  
5/20/2024Muthusamy ShanmugamCOOSell12,855$61.81$794,567.55  
5/17/2024Muthusamy ShanmugamCOOSell5,836$62.09$362,357.24  
5/16/2024Renee P TannenbaumDirectorSell2,000$63.87$127,740.00  
5/15/2024Muthusamy ShanmugamCOOSell14,850$65.86$978,021.00  
5/14/2024Nikhil LalwaniCEOSell16,669$66.10$1,101,820.90  
5/13/2024Meredith CookVPSell250$67.69$16,922.50  
5/1/2024Chad GassertSVPSell20,000$66.62$1,332,400.00  
4/19/2024Muthusamy ShanmugamCOOSell16,809$65.17$1,095,442.53  
4/17/2024Muthusamy ShanmugamCOOSell9,520$65.40$622,608.00  
4/15/2024Muthusamy ShanmugamCOOSell7,414$66.33$491,770.62  
4/12/2024Meredith CookVPSell250$67.79$16,947.50  
4/1/2024Chad GassertSVPSell20,000$67.25$1,345,000.00  
3/11/2024Stephen P CareyCFOSell7,787$65.55$510,437.85  
3/8/2024Nikhil LalwaniCEOSell16,292$67.13$1,093,681.96  
3/7/2024James G MarkenSVPSell24,338$66.37$1,615,313.06  
3/7/2024Muthusamy ShanmugamCOOSell15,085$66.35$1,000,889.75  
3/6/2024Nikhil LalwaniCEOSell28,965$65.52$1,897,786.80  
3/5/2024Muthusamy ShanmugamCOOSell10,093$65.35$659,577.55  
2/13/2024Meredith CookVPSell250$56.04$14,010.00  
1/22/2024Muthusamy ShanmugamCOOSell5,692$55.95$318,467.40  
1/18/2024Muthusamy ShanmugamCOOSell9,784$55.30$541,055.20  
1/16/2024Muthusamy ShanmugamCOOSell5,000$55.63$278,150.00  
1/12/2024Meredith CookVPSell250$56.43$14,107.50  
12/18/2023Muthusamy ShanmugamCOOSell13,026$52.44$683,083.44  
12/15/2023Muthusamy ShanmugamCOOSell11,974$52.44$627,916.56  
12/11/2023Meredith CookVPSell250$49.21$12,302.50  
(Data available from 1/1/2013 forward)

ANIP Insider Trading Activity - Frequently Asked Questions

The list of insiders at ANI Pharmaceuticals includes Antonio R Pera, Chad Gassert, Christopher Mutz, James G Marken, Jeanne Thoma, Krista Davis, Meredith Cook, Meridian Venture Partners Ii L, Muthusamy Shanmugam, Nikhil Lalwani, Ori Gutwerg, Patrick D Walsh, Renee P Tannenbaum, Stephen P Carey, and Thomas Haughey. Learn more on insiders at ANIP.

12.70% of ANI Pharmaceuticals stock is owned by insiders. Learn more on ANIP's insider holdings.

The following insiders have sold ANIP shares in the last 24 months: Antonio R Pera ($181,110.00), Chad Gassert ($10,774,200.00), Christopher Mutz ($123,220.00), James G Marken ($1,615,313.06), Krista Davis ($141,089.82), Meredith Cook ($149,875.00), Meridian Venture Partners Ii L ($11,700,000.00), Muthusamy Shanmugam ($22,741,366.05), Nikhil Lalwani ($8,075,837.24), Ori Gutwerg ($1,170,845.79), Renee P Tannenbaum ($127,740.00), and Stephen P Carey ($828,337.85).

Insiders have sold a total of 963,995 ANI Pharmaceuticals shares in the last 24 months for a total of $57,628,934.81 sold.

ANI Pharmaceuticals Key Executives

  • Mr. Nikhil  LalwaniMr. Nikhil Lalwani (Age 46)
    President, CEO & Director
    Compensation: $2.32M
  • Mr. Stephen P. CareyMr. Stephen P. Carey (Age 53)
    Senior VP of Finance & CFO
    Compensation: $1.11M
    1 recent trades
  • Mr. Chad Gassert (Age 48)
    Senior Vice President of Corporate Development & Strategy
    Compensation: $849.71k
    2 recent trades
  • Mr. Christopher K. Mutz (Age 52)
    Senior Vp & Head of Rare Disease
    Compensation: $867.92k
  • Mr. Ori Gutwerg (Age 49)
    Senior Vice President of Generics
    Compensation: $895.16k
    1 recent trades
  • Mr. Muthusamy Shanmugam MS R.Ph. (Age 56)
    Head of R&D, COO of Novitium Operations & Director
  • Mr. James G. Marken (Age 61)
    Senior Vice President of Operations
    Compensation: $673.23k
  • Ms. Elizabeth Powell J.D.
    Chief Compliance Officer & Head of Legal of Rare Disease
  • Ms. Meredith W. Cook (Age 49)
    Senior VP, General Counsel & Corporate Secretary
    5 recent trades
  • Ms. Krista L. Davis (Age 50)
    Senior VP & Chief Human Resources Officer


This page (NASDAQ:ANIP) was last updated on 11/27/2024 by MarketBeat.com Staff
From Our Partners